---
$id: https://graph.org.ai/products/commodity/51281606
$type: Product
source: UNSPSC
code: "51281606"
title: "Betamicin"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Betamicin

**UNSPSC Code**: 51281606
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an aminoglycoside antibiotic with the molecular formula C19H38N4O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 67W9DGG4C7 chemically known as d-streptamine, o-6-amino-6-deoxy-.alpha.-d-glucopyranosyl-(1->4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl-(1->6))-2-deoxy- but generally known as betamicin, which bears US NIH Compound Identifier 37569. European Medicines Agency schedules Betamicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05799MIG. The term BETAMICIN is an International Non-Proprietary Name or INN. Most nations schedule betamicin under HS 29419000 and SITC 54139. As of Q4 2014, BETAMICIN remains the US FDA Preferred Term for this commodity. Betamicin bears US NLM identifiers UMLS ID C0061208 and NCI Concept Code C81375. SMILES: O(C1C(O)C(OC2OC(C(O)C(O)C2O)CN)C(N)CC1N)C1OCC(O)(C(NC)C1O)C.

